MARIAH MESSMER: Open Payments
NPI 1477204055 · FRENCH LICK, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 15 payments from 9 companies in 2025. Trend: 2023 $163 · 2024 $171 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| ABBVIE INC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Amgen Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VRAYLAR, LEQVIO, FARXIGA, OTEZLA, Kerendia, Ozempic, Wegovy, TRINTELLIX.
Industry payments across IN — which companies pay providers there.
